175 related articles for article (PubMed ID: 3341098)
1. Ketoconazole therapy for hormonally refractive metastatic prostate cancer.
Johnson DE; Babaian RJ; von Eschenbach AC; Wishnow KI; Tenney D
Urology; 1988 Feb; 31(2):132-4. PubMed ID: 3341098
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy of prostatic bone metastases.
Huben RP
Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
[TBL] [Abstract][Full Text] [Related]
3. High dose ketoconazole for the treatment of hormone refractory metastatic prostate carcinoma: 16 cases and review of the literature.
Jubelirer SJ; Hogan T
J Urol; 1989 Jul; 142(1):89-91. PubMed ID: 2659829
[TBL] [Abstract][Full Text] [Related]
4. Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status?
Leo ME; Bilhartz DL; Bergstralh EJ; Oesterling JE
J Urol; 1991 Apr; 145(4):802-6. PubMed ID: 1706440
[TBL] [Abstract][Full Text] [Related]
5. Indications for use of ketoconazole in management of metastatic prostate cancer.
Lowe FC; Bamberger MH
Urology; 1990 Dec; 36(6):541-5. PubMed ID: 2247927
[TBL] [Abstract][Full Text] [Related]
6. Relapse on endocrine treatment in patients with stage D2 prostate cancer. Does second-line hormonal therapy affect survival?
Matzkin H; Rangel MC; Soloway MS
Urology; 1993 Feb; 41(2):144-8. PubMed ID: 8497986
[TBL] [Abstract][Full Text] [Related]
7. Early combined hormonal and chemotherapy for metastatic prostatic carcinoma.
Servadio C; Mukamel E; Lurie H; Nissenkorn I
Urology; 1983 May; 21(5):493-5. PubMed ID: 6857889
[TBL] [Abstract][Full Text] [Related]
8. Effects of castration compared with total androgen blockade on tissue dihydrotestosterone (DHT) concentration in benign prostatic hyperplasia (BPH).
Geller J; Albert J
Urol Res; 1987; 15(3):151-3. PubMed ID: 3629749
[TBL] [Abstract][Full Text] [Related]
9. High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.
Trump DL; Havlin KH; Messing EM; Cummings KB; Lange PH; Jordan VC
J Clin Oncol; 1989 Aug; 7(8):1093-8. PubMed ID: 2474059
[TBL] [Abstract][Full Text] [Related]
10. The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.
Servadio C
Prog Clin Biol Res; 1987; 243B():449-53. PubMed ID: 3659039
[No Abstract] [Full Text] [Related]
11. Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer.
Amato RJ; Hernandez-McClain J; Henary H
Am J Clin Oncol; 2008 Dec; 31(6):532-8. PubMed ID: 19060583
[TBL] [Abstract][Full Text] [Related]
12. Megestrol acetate in relapsed carcinoma of prostate.
Daniel F; MacLeod PM; Tyrrell CJ
Br J Urol; 1990 Mar; 65(3):275-7. PubMed ID: 2186841
[TBL] [Abstract][Full Text] [Related]
13. Management of metastatic prostatic carcinoma.
Drug Ther Bull; 1986 Nov; 24(22):85-8. PubMed ID: 2430768
[No Abstract] [Full Text] [Related]
14. Effects of high-dose ketoconazole on patients who have androgen-independent prostatic cancer.
Eichenberger T; Trachtenberg J
Can J Surg; 1989 Sep; 32(5):349-52. PubMed ID: 2475237
[TBL] [Abstract][Full Text] [Related]
15. Treatment of metastatic carcinoma of the prostate.
Goethuys H; Baert L; Van Poppel H; Lieskovsky G; Brady LW; Petrovich Z
Am J Clin Oncol; 1997 Feb; 20(1):40-5. PubMed ID: 9020286
[TBL] [Abstract][Full Text] [Related]
16. Complete androgen blockade for the treatment of prostate cancer.
Labrie F; Dupont A; Belanger A
Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
[No Abstract] [Full Text] [Related]
17. Effects of high-dose ketoconazole in patients with androgen-independent prostatic cancer.
Eichenberger T; Trachtenberg J
Am J Clin Oncol; 1988; 11 Suppl 2():S104-7. PubMed ID: 3242385
[TBL] [Abstract][Full Text] [Related]
18. Ketoconazole high dose in management of hormonally pretreated patients with progressive metastatic prostate cancer. Dutch South-Eastern Urological Cooperative Group.
Witjes FJ; Debruyne FM; Fernandez del Moral P; Geboers AD
Urology; 1989 May; 33(5):411-5. PubMed ID: 2652864
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of prostate volume by ultrasound in hormonally treated prostate cancer.
Brandt B; Menu G; el Khansa A; Lardennois B
Prog Clin Biol Res; 1987; 243B():13-9. PubMed ID: 3309979
[No Abstract] [Full Text] [Related]
20. Hormonal therapy of prostatic carcinoma. Defining the challenge.
Crawford ED
Cancer; 1990 Sep; 66(5 Suppl):1035-8. PubMed ID: 2203516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
